The global immunoassay CDMO market is poised for significant expansion, with market projections estimating a value of USD 11,274.0 million in 2025. The market is expected to grow at a robust CAGR of 8.9% between 2025 and 2035, reaching a valuation of USD 26,528.5 million by 2035. This remarkable growth trajectory is fueled by rising …